SCHEMBL6550260

SCHEMBL6550260

N/C(CS(=O)(=O)c1ccccc1)=N/O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.68
HSD11B1 P28845 7/20 0.50
ALDH1A1 P00352 2/20 0.47
TP53 P04637 2/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PSIP1 O75475 1/20 0.47
MMP2 P08253 1/20 0.46
MMP7 P09237 1/20 0.46
MMP14 P50281 1/20 0.46
KMT2A Q03164 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 1/20 0.45
S1PR2 O95136 1/20 0.45
LMNA P02545 1/20 0.45
PRNP P04156 1/20 0.45
MAPT P10636 1/20 0.45
XBP1 P17861 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6428540 1.00 POLB (0.68) POLBHSD11B1ALDH1A1TP53HTT
SCHEMBL7427351 0.86 POLB (0.59) POLBHSD11B1ALDH1A1TP53HTT
SCHEMBL4154460 0.81 F2 (0.49) POLBHSD11B1ALDH1A1MMP2KMT2A
SCHEMBL11554583 0.81 NPC1 (0.66) POLBHSD11B1ALDH1A1NPC1LMNA
SCHEMBL10399093 0.80 F2 (0.54) POLBALDH1A1HTTNPC1LMNA
SCHEMBL10399095 0.80 F2 (0.54) POLBALDH1A1HTTNPC1LMNA
SCHEMBL2805655 0.78 ALDH1A1 (0.66) POLBHSD11B1ALDH1A1TP53HTT
Hydrochloric Acid SCHEMBL19066539 0.76 ALDH1A1 (0.63) POLBHSD11B1ALDH1A1TP53HTT
SCHEMBL5467897 0.76 HSD11B1 (0.53) POLBHSD11B1ALDH1A1TP53HTT
SCHEMBL9136704 0.76 HSD11B1 (0.53) POLBHSD11B1ALDH1A1TP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1240152-B1 OX(ADI)AZOLYL-HYDROXAMIC ACIDS USEFUL AS PROCOLLAGEN C-PROTEINASE INHIBITORS PFIZER LTD (GB) 2004-12-08 EP disclosed
EP-1240152-A1 OX(ADI)AZOLYL-HYDROXAMIC ACIDS USEFUL AS PROCOLLAGEN C-PROTEINASE INHIBITORS Pfizer Limited (GB) 2002-09-18 EP disclosed
US-6448278-B2 ANTISCARRING AGENT PFIZER INC. 2002-09-10 US disclosed
US-20010021718-A1 Procollagen C-proteinase inhibitors PFIZER INC. 2001-09-13 US disclosed
WO-2001047901-A1 OX(ADI)AZOLYL-HYDROXAMIC ACIDS USEFUL AS PROCOLLAGEN C-PROTEINASE INHIBITORS PFIZER LIMITED (GB) 2001-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010021718-A1 Procollagen C-proteinase inhibitors MMP1, CTSL, PREP POLB 2707/4885HSD11B1 1569/4885ALDH1A1 1866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.